Related Experiment Video
Updated: Aug 9, 2026
07:04
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Cystic fibrosis clinical trials
1Ion Transport Unit, National Heart and Lung Institute, Emmanuel Kaye Building, Manresa Road, London SW3 6LR, UK
Advanced Drug Delivery Reviews
|June 6, 2000
Summary
Cystic Fibrosis (CF) involves ion transport defects. Research explores correcting these through drugs or gene therapy, with gene therapy showing promising progress in clinical trials for CF treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Science
Background:
- Cystic Fibrosis (CF) is characterized by ion transport abnormalities.
- The precise mechanisms linking these defects to lung pathology remain under investigation.
- Understanding these mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To review current strategies for correcting ion transport defects in CF.
- To evaluate the potential of pharmacological and gene therapy approaches.
- To highlight the progress and challenges in translating these therapies into practice.
Main Methods:
- Review of existing literature on CFTR protein function and dysfunction.
- Analysis of pharmacological strategies targeting CFTR protein localization and function.
- Assessment of gene therapy approaches, including delivery methods and clinical trial outcomes.
Main Results:
- Pharmacological strategies aim to increase CFTR protein levels at the correct site or enhance its function.
- Alternative ion channels are being explored to compensate for CFTR dysfunction.
- Gene therapy offers a theoretical solution by addressing all identified CF defects.
Conclusions:
- Significant progress has been made in developing both pharmacological and gene therapy for CF.
- The primary challenge for gene therapy lies in efficient in vivo delivery of the CFTR gene.
- Clinical trials indicate encouraging advancements in moving CFTR-targeted therapies from theory to practice.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...